Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Baik Young-chul
|
| gptkbp:collaboratedWith |
IVI (International Vaccine Institute)
|
| gptkbp:country |
gptkb:South_Korea
|
| gptkbp:exportedTo |
multiple countries
|
| gptkbp:founded |
2010
|
| gptkbp:headquarters_location |
gptkb:Seoul
|
| https://www.w3.org/2000/01/rdf-schema#label |
EuBiologics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:KOSDAQ
|
| gptkbp:notable_for |
oral cholera vaccine
|
| gptkbp:product |
gptkb:Euvichol
gptkb:Euvichol-Plus |
| gptkbp:received_WHO_prequalification |
gptkb:Euvichol
|
| gptkbp:specializesIn |
vaccines
|
| gptkbp:stockSymbol |
206650
|
| gptkbp:website |
https://www.eubiologics.com
|
| gptkbp:bfsParent |
gptkb:Euvichol
|
| gptkbp:bfsLayer |
7
|